These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3508397)

  • 21. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

  • 22. [The significance of studying the HBe system in the prognosis of patients with acute and chronic viral hepatitis Be].
    Perisić-Savić M; Nastić-Mirić D
    Srp Arh Celok Lek; 1983; 111(9-10):1343-50. PubMed ID: 6681452
    [No Abstract]   [Full Text] [Related]  

  • 23. Correlation between HBeAg/anti-HBe and other hepatitis B virus (HBV) markers in healthy carriers.
    Musca A; Cordova C; Barnaba V; Zaccari C
    Quad Sclavo Diagn; 1981 Sep; 17(3):363-9. PubMed ID: 7343989
    [No Abstract]   [Full Text] [Related]  

  • 24. Preference and significance of HBeAg and anti-HBe, determined by enzyme immunoassay, in patients with acute, chronic and resolved hepatitis B.
    Niermeijer P; Gips CH; Huizenga JR; van der Waart M; Schuurs A
    Hepatogastroenterology; 1980 Oct; 27(5):350-5. PubMed ID: 7203369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The HBe antigen-antibody system and its relationship to epidemiological, histological and biochemical findings in patients with HBV+ HDV chronic liver diseases.
    Jelić D; Jelić O
    Acta Med Croatica; 1994; 48(2):77-83. PubMed ID: 7519502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative study of the "e" system (HBeAG/anti-HBeAg) and core antibodies in aggressive chronic hepatitis and liver cirrhosis].
    Marinucci G; Muglia M; Di Giacomo C; Petrucci L; Mancini R; Costa F; Bachetoni A
    Quad Sclavo Diagn; 1981 Mar; 17(1):81-5. PubMed ID: 7313073
    [No Abstract]   [Full Text] [Related]  

  • 27. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels.
    Chu CM; Hung SJ; Lin J; Tai DI; Liaw YF
    Am J Med; 2004 Jun; 116(12):829-34. PubMed ID: 15178498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of alcohol on the liver in HBsAg carriers.
    Itoh S; Shimoji K
    Am J Gastroenterol; 1986 Sep; 81(9):779-82. PubMed ID: 3752040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of HBe-Ag and anti-HBe in asymptomatic HBs-Ag carriers and patients with liver disease.
    Shanmugam J; Balakrishnan V; Thomas M; Jayaprakash PA
    Indian J Pathol Microbiol; 1983 Jan; 26(1):1-5. PubMed ID: 6315579
    [No Abstract]   [Full Text] [Related]  

  • 30. HBeAg and anti-HBe in chronic hepatitis B virus infection.
    Chen DS; Sung JL; Lai MY
    Gastroenterology; 1981 Apr; 80(4):880-2. PubMed ID: 7202958
    [No Abstract]   [Full Text] [Related]  

  • 31. Transmission of a homogenous hepatitis B virus population of A1896-containing strains leading to mild resolving acute hepatitis and seroconversion to hepatitis B e antigen antibodies in an adult.
    Mphahlele MJ; Shattock AG; Boner W; Quinn J; McCormick PA; Carman WF
    Hepatology; 1997 Sep; 26(3):743-6. PubMed ID: 9303507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinico-prognostic significance of partial seroconversion in chronic viral hepatitis B follow-up. Wartenbert Study (1974-1994), II].
    Ohlen I; Liegl JM; Selmair H
    Leber Magen Darm; 1995 Dec; 25(6):259-62. PubMed ID: 8577215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hbeag/Anti-hbe system and other markers for hepatitis b in a dialysis unit (author's transl)].
    Turci F; Iosa G; Cipolloni A; Cenciotti L
    Quad Sclavo Diagn; 1980 Dec; 16(4):349-55. PubMed ID: 7244108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.
    Hsu YS; Chien RN; Yeh CT; Sheen IS; Chiou HY; Chu CM; Liaw YF
    Hepatology; 2002 Jun; 35(6):1522-7. PubMed ID: 12029639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Viral markers of hepatitis A and B: main characteristics and clinical significance].
    Lyra LG
    Arq Gastroenterol; 1983; 20(3):117-22. PubMed ID: 6329145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical course and outcome of acute hepatitis B in relation to the markers of the E system].
    Iushchuk ND; Shestakova IV; Klimova EA; Sergeeva NA; Malyshev NA; Braginskiĭ DM; Favorov MO
    Ross Med Zh; 1992; (4):42-4. PubMed ID: 1521021
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis.
    Liaw YF; Chu CM; Su IJ; Huang MJ; Lin DY; Chang-Chien CS
    Gastroenterology; 1983 Feb; 84(2):216-9. PubMed ID: 6848402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognostic value of HBe antigen and anti-HBe antibody in viral hepatitis B (author's transl)].
    Chossegros P; Trepo C; Brette R; Chevallier P; Vitviski L; Sepetjan M
    Nouv Presse Med; 1981 May; 10(24):1993-6. PubMed ID: 7255135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of hepatitis B surface antigen, hepatitis B e antigen and antibody, and antigen subtypes in atomic bomb survivors.
    Neriishi K; Akiba S; Amano T; Ogino T; Kodama K
    Radiat Res; 1995 Nov; 144(2):215-21. PubMed ID: 7480648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HBeAG and anti-HBe in the Malaysian population and in Malaysian prisoners.
    Ton SH; Lopez CG; Noriah R
    Southeast Asian J Trop Med Public Health; 1983 Jun; 14(2):252-4. PubMed ID: 6635764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.